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1 INTRODUCTION 
Aggregatibacter actinomycetemcomitans is a bacterium linked to aggressive periodontitis 
and is considered a putative pathogen also in some systemic diseases. Seven serotypes (a-
g) of A. actinomycetemcomitans have been so far identified. In this study, we have 
developed a methodology to identify these serotypes by using quantitative PCR qPCR) 
(the serotype g is excluded from the study). 
Advanced methods to identify serotypes of putative pathogens should support research 
on periodontitis and role of oral microbes also in systemic diseases and distant infections 
outside oral cavity. QPCR is a relatively affordable and quick method for bacterial 
characterization. 
The phases of method development are following: designing serotype specific primers, 
developing and testing an efficient and sensitive qPCR assay for the primers, cross 
checking the primers with control templates using cultivated bacteria from pure cultures 
and clinical saliva samples. 
2 REVIEW OF THE LITERATURE 
2.1 Periodontal disease 
Gingivitis and periodontitis are diseases affecting the tissue surrounding the teeth. Both 
of the conditions are manifestations of an inflammation reaction caused by bacteria and 
the major difference between these conditions is in the severity and extent of the reaction. 
The inflammation reaction is caused by dysbiosis of the bacterial biofilm on dental 
surface. 
In gingivitis, the symptoms are redness, swelling, tenderness and bleeding of the gingiva. 
In periodontitis, the inflammation leads to irreversible destruction of periodontal 
ligament, the clinical definition being detectable attachment loss.(1) The change in the 
periodontal tissue is manifested in deepening of the crevice between the gingiva and the 
tooth. In progressing periodontitis, the crevice deepens to form a periodontal pocket 
towards the root of the tooth. Eventually the disease can cause alveolar bone resorption 
and tooth loss.(2) In periodontitis, the gram-negative and anaerobic bacteria become more 
prevalent in oral microbiota compared to gingivitis with a gram-positive majority. Also, 
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the number of bacteria may rise from 1x10³ to 1x108 in periodontal pocket.(2) Clinically 
the disease is diagnosed by measuring the probing depth, i.e. depth of periodontal pockets, 
bleeding of the gingiva, amount of plaque, calculus, and exudate. Also, radiography is 
essential in analysis of loss of alveolar bone.(2) 
Periodontitis is classified to three different diseases or forms, chronic periodontitis, 
aggressive periodontitis, and periodontitis as a manifestation of a systemic disease. 
Difference between these diseases is made following the rate of progress of the disease, 
patterns of destruction, age of onset, clinical signs of inflammation, and amount of dental 
plaque and calculus. The symptoms of periodontitis may be localized or generalized, 
meaning that the periodontal attachment loss either affects only some of the teeth, or 
manifests itself in all teeth.(3) Localized aggressive periodontitis differs from the other 
forms in three different ways. It affects only the periodontal ligament around incisors and 
first molars and it is associated with thin dental plaque, in contrast to chronic and general 
aggressive periodontitis which are characterized by relatively thick plaque and calculus. 
The same applies to clinical signs of inflammation, which tend to be obvious in chronic 
and generalized aggressive periodontitis in comparison to localized aggressive 
periodontitis with relatively modest signs of clinical inflammation. Regarding the age of 
onset of periodontitis, it is accepted that aggressive periodontitis clearly affects younger 
people than chronic periodontitis. Localized aggressive periodontitis is considered to 
have its onset in puberty and generalized aggressive periodontitis affects usually patients 
under 30 years old.(4,5) 
The classification of periodontitis presented above is based on work done by the 
International Workshop for Classification of Periodontal Diseases and Conditions and 
American Academy of Periodontology in 1999. Even though this classification is widely 
accepted, the understanding of the disease evolves, as does the classification.(6) It is 
important to note when assessing research data and findings on periodontitis that there is 
variation in the criteria that are used to describe study subjects as patients with 
periodontitis or healthy. Hence, the criteria on whether study subjects have periodontitis 
or not, needs to be stated when reported prevalence rates are referred to. 
Periodontitis is a relatively common disease. Circa 64 per cent of Finnish population over 
30 years old suffer from periodontitis in one form or another. This figure is based on the 
Health 2000 study conducted in 2000 and 2001. The criteria for periodontitis were at least 
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one tooth with a probing depth 4 mm or more. Applying the same criteria, 50% of over 
30 years old in the United States and 54% of over 15 years old in England have 
periodontitis.(7) 
In the United States it has been estimated that 21.8% of the adult population (aged 
between 30 to 90 years) has the mild form of the disease, and 12.6% moderate or severe 
form of the disease. In this case, study subject was considered to have periodontitis if 
there was at least one tooth with a probing depth minimum of 3 mm or a grade I furcation 
involvement. For moderate form of periodontitis the criteria were at least one tooth with 
probing depth of 5 mm or at least two teeth having a minimum probing depth of 4 mm.(8) 
Despite the classification of periodontitis to different categories according to symptoms, 
further consensus building has been needed to standardize definitions. A study conducted 
in Brazil has demonstrated differences in prevalence rates due differing case definitions 
of periodontitis. Applying five different definitions, the researches ended up with 
prevalence rates for periodontitis ranging from 65.3% to 13.8%.(9) 
To address the issue of differing case definitions, uniform definitions have been proposed 
both by 5th European Workshop in Periodontology and by Centers for Disease Control 
and Prevention and American Academy of Periodontology. The following Tables 1 and 
2 summarize these two definitions.(10,11)  
 
Table 1: Definitions of periodontitis according to the Centers for Disease Control and 
Prevention and American Academy of Periodontology 
Case of periodontitis Definition 
No periodontitis No evidence of mild, moderate, or severe periodontitis 
Mild periodontitis ≥ 2 interproximal sites with clinical attachment loss ≥ 3 mm, and ≥ 2 
interproximal sites with probing depth ≥ 4 mm (not on same tooth) 
or one site with probing depth ≥ 5mm 
Moderate periodontitis ≥ 2 interproximal sites with clinical attachment loss ≥ 4 mm (not on 
same tooth), or ≥ 2 interproximal sites with probing depth ≥ 5 mm 
(not on same tooth) 
Severe periodontitis ≥ 2 interproximal sites with clinical attachment loss ≥ 6 mm (not on 
same tooth) and ≥ 1 interproximal site with probing depth ≥ 5mm 
Edited from Eke et al 2012.(11)  
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Table 2: Definitions of periodontitis according to the 5th European workshop in 
periodontology 
Case of periodontitis Definition 
Sensitive case 
definition (inclusive 
of incipient cases) 
Presence of proximal attachment loss of ≥ 3mm in ≥ 2 non-adjacent teeth. 
Cases with substantial 
extent and severity 
Presence of proximal attachment loss of ≥ 5mmin ≥ 30% of teeth present. 
Edited from Tonetti et al 2005.(10) 
2.1.1 Pathogenesis of periodontitis 
There is a strong link between chronic periodontitis and gingivitis. Albeit gingivitis does 
not always result in chronic periodontitis, chronic periodontitis is nearly always preceded 
by gingivitis. However, the relationship between dental plaque, gingivitis, and severe 
forms of periodontitis is not that clear. There are reasons to suggest that certain subjects 
in a population are more susceptible to the disease.(12) 
The inflammation reaction is the key in understanding the damage to the connective tissue 
and even possible resorption of alveolar bone. The destruction of connective tissue and 
resorption of alveolar bone are caused mainly by host immune reaction, including 
secretion of matrix metalloproteinases and increase in osteoclastogenesis.(13) 
Periodontitis is caused by disturbed interaction between dental biofilm and periodontal 
tissue. This interaction has been recently described through polymicrobial synergy and 
dysbiosis model (PSD model). The central idea in PSD–model is that although there are 
species strongly linked with chronic periodontitis, such as Porphyromonas gingivalis, this 
species alone is not able to initiate tissue destructive inflammation. Rather, it is suggested 
that the periodontitis is a result of synergistic and dysbiotic microbiota. Species such as 
P. gingivalis do have a key role, but they are not able to initiate dysbiosis and an 
inflammation reaction without pathobionts, which are able to contribute to the 
inflammation when homeostasis has been disrupted.(14) 
Methods based on sequencing of 16SRNA have on the one hand confirmed the earlier 
results that have linked P. gingivalis, Treponema denticola and Tannerella forsythia with 
periodontitis. On the other hand, these studies have given evidence on previously 
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unrecognized associations between periodontitis and bacteria including Anaeroglobus 
geminatus, Eubacterium saphenum, Filifactor alocis, Porphymoronas endodontalis and 
Prevotella denticola.(15) 
While the connection between some identified bacteria and periodontitis has been 
established in several studies, there are still a number of non-identified bacteria to be 
found in periodontal pockets of inflamed tissue (16). Also, while the prevalence and 
especially the amount of e.g. A. actinomycetemcomitans (and other above mentioned 
species) in samples from patients suffering of aggressive localized periodontitis is 
significantly higher than in samples from healthy patients, no individual species has been 
pinpointed as the cause for any periodontal disease (16). Hence, while certain bacteria 
such as A. actinomycetemcomitans have been strongly linked with localized aggressive 
periodontitis, and others to chronic periodontitis, the presence of this bacterium in saliva 
or dental pockets do not serve as an indication of periodontitis. An exception for this is 
the highly leucotoxic JP2 clone of A. actinomycetemcomitans.(3)  
Smokers have a higher risk to suffer from periodontitis and treatment fails more often 
with smokers than non-smokers. It is suggested that tobacco contributes to periodontitis 
by affecting vascular metabolism and inflammatory response.(17) Other environmental 
risk factors are stress and insufficient diet.(2)  
2.1.2 Links to systemic health 
Periodontitis has been linked to several systemic diseases. E.g., pulmonary disease, 
diabetes, stroke, and adverse pregnancy outcomes have been assumed to be linked with 
periodontitis, but research to establish the links is still underway.(2) 
The assumption of periodontitis as a risk factor for atherosclerotic vascular diseases 
(ASVDs) is based on both indirect and direct linkages. The association between systemic 
inflammation markers and ASVDs, and association between periodontal disease and 
systemic inflammation markers are one indirect linkage. Another indirect linkage is 
hypothesized to be result from molecular mimicry, i.e. cross reactive antibodies linking 
periodontal inflammation to cardiovascular inflammation. By direct linkages it is referred 
to transient bacteremia and vascular infection by pathogens entering circulation in 
inflamed periodontal tissue. Evidence of this link has been studied by searching putative 
periodontal pathogens in atherosclerotic plaque. DNA of these pathogens has been found 
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in samples of atherosclerotic plaque, including DNA of A. actinomycetemcomitans. At 
the time any causal relationship between periodontitis and atherosclerotic vascular 
disease are not confirmed, albeit the association between these is confirmed.(18) A link 
has been found between presence of subgingival A. actinomycetemcomitans and coronary 
artery disease(19), and salivary levels of A. actinomycetemcomitans associate with acute 
coronary syndrome.(20)  
2.2 Aggregatibacter actinomycetemcomitans 
A. actinomycetemcomitans1 is a non-motile, facultatively anaerobic gram-negative rod. 
Its primary habitat is human dental surfaces.(22) A. actinomycetemcomitans is an oral 
commensal and also considered a putative pathogen (23). Infections caused by this 
species outside oral cavity are rare, the most common being endocarditis (24). It has also 
been reported as a causative agent of an infection leading to a brain abscess (25). 
The prevalence of A. actinomycetemcomitans varies greatly between geographically and 
ethnically/racially distinct populations. In Asian populations, A. actinomycetemcomitans 
seems to be a common member of oral microbiota in healthy subjects. E.g. in Vietnamese 
children under 11 years old the isolation frequency has been 78%, whereas in Finnish 
children of the same age the frequency was 16%.(26) Also, in United States it has been 
indicated that A. actinomycetemcomitans is more common among Asian-American and 
Hispanic subjects than among Caucasian population.(27) In Finnish adults, the prevalence 
of A. actinomycetemcomitans in saliva samples of 1 294 over 29 years old subjects has 
been reported to be 20%.(28) 
2.2.1 Virulence factors of A. actinomycetemcomitans 
A. actinomycetemcomitans secretes a protein called leukotoxin (LtxA) that affects 
polymorphonuclear leukocytes, monocytes, lymphocytes, erythrocytes and endothelial 
cells in humans. The effect of leukotoxin on hosts’ cells varies from membrane dysfuntion 
to induced apoptosis, depending on the cell. Polymorphonuclear leukocytes have been 
reported to release proteolytic enzymes and matrix metalloproteinase 8 by the exposure 
to LtxA. (29) 
                                                          
1 Previous names and year of naming: Bacterium actinomycetem comitans in 1912, Actinobacillus 
actinomycetemcomitans in 1929, Haemophilus actinomycetemcomitans in 1985.(21) 
 
 7 
 
Cytolethal distending toxin (CDT) inhibits cell division and causes apoptosis. 
Furthermore, CDT has an increasing effect on expression of cytokine RANKL (NF-κB 
ligand), which has a central role in bone resorption. However, the role of CDT in 
periodontal attachment loss has not been considered relevant in research concerning A. 
actinomycetemcomitans.(29) 
2.2.2 Lipopolysaccharide and serotyping 
A. actinomycetemcomitans, like other gram-negative bacteria, has an outer membrane 
which is largely constructed of lipopolysaccharide molecules. The lipopolysaccharide is 
comprised of O-antigen, core oligosaccharide, and lipid A (Figure 1). The presence or 
absence of O chains determines whether the LPS is considered rough or smooth. Since O 
antigen is exposed on the very outer surface of the bacterial cell it is a target for recognition by 
the host antibodies. The antigen binds to receptors in the host’s cells resulting in an immune 
response.(30). The O-antigen is constructed of repetitive glycan regions containing a 
variety of monosaccharides (31). Like polysaccharides forming the bacterial capsule, the 
O-antigen protects the bacteria from phagocytosis.(30) It has not been shown that in case 
of A. actinomycetemcomitans the virulence would be determined by O-antigen (12). Also, 
A. actinomycetemcomitans strains lacking a serotypeable antigen has been identified (32). 
Serotyping methods have evolved from using immunodiffusion to identify antisera 
produced in rabbits (such as in serotyping the a, b and c serotypes of A. 
actinomycetemcomitans (33)) to advanced molecular biology methods such as 
polymerase chain reaction (PCR), gas chromatography and nuclear magnetic resonance 
(34). 
 
Figure 1: Simplified structure of lipopolysaccharide. The O-antigen is a glycan polymer and its structure 
varies between strains. The O-antigen is attached to core oligosaccharide. Lipid A is composed of 
glucosamine disaccharide and fatty acids that attach the molecule into the membrane. 
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Serotyping of gram-negative bacteria is mainly based on the variation of the O-antigen. 
There is generally high variability in the O-antigen structure in gram-negative 
bacteria.(31) 
2.3 A. actinomycetemcomitans and periodontitis 
As described above, periodontitis is a disease that is not specifically caused by any single 
bacteria. However, A. actinomycetemcomitans is linked to localized aggressive 
periodontitis in numerous studies. Research so far has not confirmed any central role for 
it in any other periodontal disease than localized aggressive periodontitis.(35)  
Some genotypes of A. actinomycetemcomitans have shown significantly higher 
leukotoxicity than others. Especially the JP2 strain of serotype b has been linked to 
aggressive periodontitis among youth of Western African or Mediterranean origin. The 
JP2 clone is endemic for populations in North Western Africa.(29)  
JP2 clone has a 530 bp deletion in the leukotoxin promoter region. Association between 
localised aggressive periodontitis and the JP2 clone of the b-serotype among Moroccan 
juveniles has been suggested by a two-year follow up study (36). In this study, subjects 
not having symptoms of periodontitis in the beginning of the study period had a 
significantly higher risk of developing localized aggressive periodontitis if they were 
carriers of the JP2 clone compared to those that either were A. actinomycetemcomitans 
positive without JP2 clone or were not carrying the species at all. Also subjects with non-
JP2 clone A. actinomycetemcomitans had a higher risk to develop localized aggressive 
periodontitis compared to those free of the bacteria. The leukotoxicity of non-JP2 
serotype b genotypes has also showed high variation and there are highly leukotoxic 
genotypes that do not have the deletion in the promoter region.(12,36,37) 
2.3.1 Serotypes of A. actinomycetemcomitans and periodontitis 
Serotypes of bacteria are considered to be of the same species, but differ from other strains 
of the same species due to the variance in cell surface antigens that produce different 
responses by the immune system. Altogether seven serotypes of A. 
actinomycetemcomitans have been identified (a-g) (34). A, b, and c were originally 
serotyped by Zambon et al (38,39). The serotypes of A. actinomycetemcomitans differ 
from each other due to distinct structures of their O-antigen components (21). The 
serotypes a, b, and c are globally most prevalent.(39)  
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A recent review concerning the role of different serotypes of A. actinomycetemcomitans 
in different forms of periodontitis and in different ethnic groups and geographical regions 
shows that there are differences in which serotype is dominant in healthy individuals and 
in patients with periodontitis depending on geographic location and ethnicity. However, 
there is no evidence to point out globally a single serotype that would be prevalent in 
samples from patients with periodontitis.(39)  
2.4 Quantitative PCR method 
PCR was developed in early 1980s. The method relies in use of DNA polymerase, an 
enzyme that is able to synthesize DNA from nucleotides copying the DNA sequence of 
the targeted DNA.  
The PCR has three temperature phases, which are denaturation, annealing, and 
elongation. In denaturation temperature the hydrogen bonds between the bases of the 
DNA strands break and DNA is in single strand form. In annealing temperature, the 
hydrogen bonds are reformed between DNA bases which allows not only for the template 
strands to reform double strand but also for the primers to anneal to the target sequences. 
Elongation temperature is optimized for the used polymerase, which performs the actual 
replication of the amplicon. 
QPCR is based on polymerase chain reaction, but differs from conventional PCR in that 
the accumulation of products can be measured for each cycle. The measurement on 
amplified DNA can be measured by using fluorescent methods that are either specific or 
non-specific for the targeted DNA sequence, called the amplicon. In both cases, the 
increased fluorescence in the reaction mixture reflects the amplification of DNA, as the 
concentration of double strand DNA increases from cycle to cycle.  
The polymerase needs primers to start the replication of the target DNA. Primers are 
designed to match the targeted DNA sequence on both of the strands that are copied. Two 
primers are needed, forward and reverse, which limit the area of the DNA sequence that 
is targeted. In qPCR, the reaction components include the polymerase, a fluorescent dye, 
deoxyribose nucleotide triphosphates, MgCl2 and components that from a buffer to 
optimize the pH for the reaction.(41) The function of MgCl2 is to bring Mg
2+ into reaction. 
Mg2+ has a catalytic role in polymerase chain reaction (42).  
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Figure 2: Exponential amplification through PCR. Each cycle of PCR produces new copies of the wanted 
gene, the amplicon. Picture from Slideshare.net (40) 
2.4.1 Primer design 
Different factors guide the primer design. On the one hand, the primer should be sensitive 
and specific to the sequence targeted. On the other hand, the primers and the produced 
amplicons should be functional from the PCR reaction efficiency point of view. 
Considering the reaction efficiency, the shorter the primer is, the more efficiently it 
anneals to the target DNA. However, there is a minimum primer length as very short 
primers are not specific.(43)  
The primer design should follow the instructions provided by the equipment 
manufacturers. For Strategene 3005P the recommendation for the length of the primer is 
15-30 base pairs. In addition to length, design of the primers should take into account the 
base composition so that the melting temperature of the primers is similar. Furthermore, 
the base composition should not allow folding of the primer on to itself.(44) The design 
of the 3’ end of the primer is crucial, as the polymerase will start the elongation process 
from an annealed 3’ end.(43) 
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The reaction spanned by the primers, i.e. amplicon length, should be between 100 and 
300 base pairs for SYBR Green I when using Stratagene 3005P. This is longer than it is 
recommended for probe based methods, as the longer the amplicon is, the more SYBR 
Green dye molecules can bind to amplified product. However, if SYBR green is used 
having in mind future use of probes, the length should be kept closer to the minimum 
length.(44) 
2.4.1 Controlling the results 
The specificity of the primers can be controlled by analysing the dissociation curve. The 
dissociation curve shows the temperature in which the double strand DNA in the assay 
melt, i.e. the hydrogen bonds between the pairing strands break. The segment three in 
Figure 3 represents the phase where qPCR machinery measures the melting point. The 
dissociation curve should display only one peak to show that the DNA products have 
similar length and similar base pair composition. The longer a DNA double strand is, the 
higher the dissociation temperature as the amount and hence the strength of hydrogen 
bonds is bigger. The effect of base pair composition is due to the difference between 
number of hydrogen bonds between CG and AT bases. 
3 AIMS OF THE STUDY 
The study aims at developing a method to identify serotypes of A. 
actinomycetemcomitans by using quantitative PCR. The method development consist of 
following phases: Designing primers that are sensitive and specific for the target DNA, 
optimising the PCR reaction, testing the designed primers by using cultivated strains of 
the target species as templates and applying the method on clinical samples. 
4 MATERIALS AND METHODS 
4.1.1 QPCR with SYBR® Green 
The commercial kit used in this study is Brilliant III ultra-fast SYBR® Green master mix. 
The fluorescent dye, SYBR® Green I, is a non-specific dye that binds to any double 
stranded DNA.(44,45) The qPCR instrument used is the Stratagene Mx3005P Real-Time 
QPCR System. The results were analysed with Strategene MxPro software (46). The 
reference dye used in this study is ROX by Agilent Technologies.(44) 
 12 
 
The concentrations of different components for qPCR on Stratagene Mx3005P are given 
by the manufacturer of the reaction mixture.(45) The volumes are listed in Table 3.  
The pipetting of different components was done in a laminar flow hood, which along with 
the necessary instruments were swiped with ethanol in the beginning of each session.  
Table 3: Volumes of reaction components per sample. 
 Volume (µl) 
Brilliant III Ultra-Fast SYBR® Green Master Mix 10 
F-primer 10 µM 0,4 
R-primer 10 µM 0,4 
ROX 1:500 dilution 0,3 
H2O 6,9 
Template 2 
Total 20 
 
4.1.2 Reference strains 
Forward and reverse primers acquired from Thermo Scientific were tested with reference 
strains representing six serotypes (a-f) of A. actinomycetemcomitans. The tests were done 
on both DNA that was purified from bacterial colonies and also on bacterial samples 
transferred directly from colonies on blood agar to purified water. The strains were grown 
on supplemented Brucella agar plates (containing 5% horse blood, hemin [5 μg/ml], 
vitamin K1 [100 mg/ml], and Brucella agar) and incubated in an atmosphere of 5% CO2 
at 37°C for 3 days. The cultures were transferred into Todd-Hewitt broth (3% TH, 1% 
yeast extract), where they were further grown for 2 days under the conditions mentioned 
below. We confirmed the purity of the cultures by colony morphology and Gram staining. 
After removing the broth by centrifugation at 5,500 × g at room temperature for 15 min, 
the bacteria were washed with phosphate-buffered saline (PBS) (10 mM phosphate [pH 
7.4], 150 mM NaCl) and DNA was extracted by phenol-chloroform method by Saija 
Perovuo.  
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Table 4: A. actinomycetemcomitans reference strains used in the study 
Serotype Strain 
a ATCC 29523 
b ATCC 43718 
c ATCC 33384 
d IDH 781 
e IDH 1705 
f CU 1000 
ATCC, American Type Culture Collection; IDH, Institute of Dentistry, University of Helsinki. 
The extracted DNA and non-purified bacterial samples were diluted in purified nuclease 
free H2O. The same H2O was used to dilute the reference dye and the reaction mixture 
for the samples. 
4.1.3 Thermal profile setup 
The thermal profile used in this study follow the recommendations from Agilent 
technologies for the used instrument Stratagene Mx3005P and is presented in Figure 3. 
The denaturation temperature was set to 95 °C. The recommended annealing 
temperature is 60 °C. The used Taq polymerase is designed to function optimally in the 
annealing temperature, thus the thermal profile had only two steps, the annealing, and 
elongation temperature both being 60 °C. 
T
em
p
er
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u
re
 (
°C
) 
 
Figure 3: Standard thermal profile used in this study. 
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4.1.4 Primers 
We designed the primers to match the target sequences Primer-BLAST developed at 
National Center for Biotechnology Information. The Primer-BLAST assists in primer 
sequence design following user given parameters for the target species and specificity 
checking utilising different genome databases.(47) The primers were designed by PhD 
Kati Hyvärinen with Primer-Blast and manufactured by Thermo Scientific. 
The primer nucleotide sequence for each serotype is presented in Table 5. The primers 
were first dissolved in H2O and then diluted to concentration of 10 µM. The primers were 
stored in temperature of -20 ˚C. 
Table 5: The primer sequences used in the study for A. actinomycetemcomitans 
Serotype Sequence 
 Forward Reverse 
a 5’-ACTGGTGCATCAGGTCAAGA -3’ 5’-TGAGCTGCTACGCCGATAAG-3’ 
b 5’-TCTCAATGTGACGCAGCTCT-3’ 5’-TGTTCATCACGACAGGGCAA-3’ 
c 5’-TTTGGACCAACAGGGGTTGA-3’ 5’-CAAAAGCACTCCGACAGCAG-3’ 
d 5’-TGCGGACAAGCGTAGTGAAT-3’ 5’-CCATAGACCTATACCGCCTCC-3’ 
e 5’-TGGGCATTTATTCAGCCAGTCA-3’ 5’-ACCATTCCTGCAATCAACCA-3’ 
f 5’-GGCGGAGATAGTTCTTGGCA-3’ 5’-ACAACCCCTCCTACCTCACA-3’ 
4.1.5 Study population 
The developed primers were tested on samples from a Finnish study population that 
participated in Parogene study (part of Corogene study) between years 2006 and 
2008.(48) DNA extracts from saliva samples of the Parogene patients have been studied 
to find links between A. actinomycetemcomitans and coronary artery disease. In the 
current study, serotype-specific qPCR was applied to DNA extracted from saliva samples 
from patients (n=264). These patients were selected among the whole cohort, since their 
subgingival bacterial samples had been found positive for A. actinomycetemcomitans. 
Among these patients, 54 saliva samples had also been found A. actinomycetemcomitans 
positive by qPCR analysis.(19,20)  
4.1.6 Plate setup 
The study was conducted in two phases. Firstly, the primers were tested with standard 
controls using reference strains described above. Primers for each serotype were tested 
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with each reference strain and a non-template control was included. Secondly, the 
Parogene samples were tested with the most optimal primers. Wells with reference strains 
for each serotype were included as controls, as well as a non-template control well with 
purified H2O. 
5 RESULTS 
5.1 Optimisation of primer concentration with Brilliant III Ultra-Fast 
SYBR Green Master Mix 
The Brilliant IIII Ultra-Fast SYBR® Green Master Mix was first tested using primers non-
specific for A. actinomycetemcomitans serotypes. These primers were originally 
developed in University of Helsinki to identify and quantify five different putative 
pathogens for periodontitis using Brilliant SYBR® qPCR Master Mix (49). Reference 
strain used in the test was ATCC 33384 (serotype c). The DNA concentration 5.26 ng/μl 
of template was measured with Nanodrop 1000. The template was diluted serially (1:10, 
1:100, 1:1000 and 1:10 000) and assays with different primer concentrations were 
prepared and analysed in qPCR. Following primer concentrations combinations for 
forward and reverse primers were tested: 
1) forward 200 nM and reverse 200 nM 
2) forward 200 nM and reverse 400 nM 
3) forward 400 nM and reverse 200 nM. 
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Figure 4: The amplification curves of dilution series for purified DNA-sample of c serotype of A. 
actinomycetemcomitans (ATCC 33384). The starting template concentration for dilution was 5.26 ng/µl. 
In this representative figure, the primer concentration is 200 nM for both forward and reverse primers. 
 
Figure 5: Standard curve for dilution series for purified DNA-sample of c serotype of A. 
actinomycetemcomitans (ATCC 33384). The starting template concentration for dilution was 5.26 ng/µl. 
Primer concentration is 200 nM for both forward and reverse primers.  
Figures 4 and 5 show the results for the primer concentration combination (200 nM for 
both forward and reverse primers) that was proven to be most efficient for the master mix 
and qPCR machinery in use. The R square value for the curve is 0.995 and efficiency 
105.7%. The respective values for combination number 2 (forward 200 nM and reverse 
400 nM) were 0.985 and 121.2% and for combination number 3 (forward 400 nM and 
reverse 200 nM) 0.962 and 135.0%. 
 
5.2 Sensitivity and specificity of the serotype-specific primers applied 
to control templates 
The primers were cross checked against each serotype. The tested primers were not 
specific enough to allow for quantification of targeted serotypes. The figure 6 shows 
amplification plots for primers designed to be specific for serotype c as an example. The 
amplification of the targeted serotype starts at an earlier cycle than that of others, but the 
primers are not specific enough for the serotype c, as the amplification occurs also in 
control wells containing DNA from other serotypes. The cross check amplification plots 
for primers designed for the other serotypes were similar to those presented in Figure 6.  
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Figure 6: Primers designed for serotype c cross-reacted with other serotypes. The green line exceeding 
the threshold level on cycle 13 is the well including bacterial residues from cultivated c strand. The other 
wells where fluorescence has risen contain serotypes a, d, f, and b. 
While the analysis of the amplification plots proved not to be a reliable method, analysis 
of dissociation curves were more useful to identify serotypes. The Figures 7–12 show the 
dissociation curves for respective primers cross tested with serotypes a–f.  
Comparison of dissociation curves show that products in the targeted serotype specimen 
have a specific melting temperature that differs from that of the other serotypes. 
Furthermore, the considerably higher fluorescence values indicate that the amount of 
amplified DNA is much higher in the wells containing the targeted serotype. 
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The dissociation curves for each serotype: 
Figure 7: The dissociation curve of serotype a. The dissociation curve shows the products in templates containing a-
serotype to dissociate in temperature of 78.6 °C differing from products amplified from templates containing 
cultivated samples from other serotypes. The primers used in the assay were designed for serotype a. 
Figure 8: The dissociation curve shows the products in templates containing b-serotype to dissociate in temperature 
of 77.4 °C differing from products amplified from templates containing cultivated samples from other serotypes. 
The primers used in the assay were designed for serotype b. 
Figure 9: The dissociation curve shows the products in templates containing c-serotype to dissociate in temperature 
of 76.4 °C differing from products amplified from templates containing cultivated samples from other serotypes. 
The primers used in the assay were designed for serotype c.  
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Figure 10: The dissociation curve shows the products in templates containing d-serotype to dissociate in 
temperature of 75.3 °C differing from products amplified from templates containing cultivated samples from other 
serotypes. The primers used in the assay were designed for serotype d. 
Figure 11: The dissociation curve shows the products in templates containing e-serotype to dissociate in 
temperature of 76.4 °C differing from products amplified from templates containing cultivated samples from other 
serotypes. The primers used in the assay were designed for serotype e. 
Figure 12: The dissociation curve shows the products in templates containing f-serotype to dissociate in temperature 
of 78.5 °C differing from products amplified from templates containing cultivated samples from other serotypes. The 
primers used in the assay were designed for serotype f. 
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5.3 The sensitivity and specificity of the primers applied to DNA 
extracts from saliva samples 
DNA extracted from saliva samples from the Parogene population was tested with the 
serotype specific primers. By analysing the dissociation curves from 252 samples, the 
serotype was identified in 44 samples (17.5 % of the samples). Out of these 44 samples, 
22 were found A. actinomycetemcomitans positive by Hyvärinen et al.(20) Figure 13 
shows how serotype b positive saliva samples are identified with primers designed for 
serotype b. The highest peak is the control template (cultivated b-serotype). The 
dissociation curves show that seven wells out of 72 unknown samples are serotype b 
positive. 
 
Figure 13: When using primers designed for b-serotype, the dissociation curve shows that seven samples 
(out of 72 unknown) from Parogene study are serotype b positive. The PCR products melt in the same 
temperature ranging between 76.7 and 77.6°C) as those for the control template containing a sample 
from b-serotype cultivation (the highest peak).  
The figure 14 shows the distribution of serotype positive samples out of 252 tested 
samples. The most prevalent serotype was c, the other serotypes following in descending 
order b, a, e, and f. 
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Figure 14: Serotype distribution of serotype positive samples (amount and percentage). Out of 252 tested 
samples the serotype could be identified in 44 samples.  
6 DISCUSSION 
In this study, a method to serotype A. actinomycetemcomitans bacteria by quantitative 
PCR was developed. Firstly, primer sets for each serotype (a–f) were planned with the 
help of genome database. Primer sequence was planned to correspond to LPS O-antigen, 
which is the bacterial structure that differentiates the serotypes from each other.  Serotype 
g was excluded due to lack of the reference strain. 
Secondly, the most efficient primer concentrations were found by experimenting with 
three different primer concentrations. The primers tested with Brilliant IIII Ultra-Fast 
SYBR® Green Master Mix using Stratagene Mx3005p qPCR machinery.  
Thirdly, the primers were cross-checked against other serotypes of A. 
actinomycetemcomitans by using cultivated reference strains. In this process, the most 
specific and sensitive primers were chosen for the next phase. Fourthly, the developed 
primers were further tested on saliva samples from 252 A. actinomycetemcomitans 
positive individuals from the Finnish Parogene study.  
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Uniqueness of the DNA sequence that the primers are designed for is crucial for the 
specificity of quantitative-PCR. The results of the tests conducted in this study show that 
the developed primers are specific enough to identify different serotypes from each other, 
even though the specificity of the primers was not enough for quantification purposes. 
The identification of the serotypes was done based on the analysis of dissociation curves. 
The PCR products in the target serotype wells dissociated in a specific temperature 
making it possible to identify respective serotype from each other. Furthermore, the 
relative proportion of each serotype is not in contradiction with findings in population 
studies.  
If developed further, the specificity of the primers should be increased and hence the 
study design redeveloped. The advantage of SYBR® Green I is that assay design is 
simpler and costs are lower compared to more specific methods. The obvious 
disadvantage of the SYBR® Green I is that the fluorescence levels are affected in the 
assay by the presence of any double strand DNA, whether it is DNA comprised of the 
target sequence (amplicon), primer-dimer or other nonspecific products containing a 
double strand of DNA.(50) The advantage of increased specificity is that is makes 
possible quantification of bacterial samples. Quantified information on samples increases 
possibilities to analyse research data.  
A worthwhile option would be to use a probe-based method to separate different serotypes 
from each other. For example, Applied Biosystems’ hydrolysis probe (trade mark 
TaqMan probe) is a DNA strand designed to match the amplified sequence between the 
forward and reverse primers. A reporter and a quencher molecule are attached to the 
probe. The presence of the quencher suppresses the fluorescence emitted by the reporter. 
When the polymerase reaches the sequence where the probe is attached, it cleaves the 
probe and releases the reporter dye. Consequently, the reporter and the quencher are 
separated and the signal emitted by the reporter dye increases. The method is specific as 
the fluorescence will increase only when a probe annealed to a specific target sequence 
is cleaved of when amplification is in the process.(50)   
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